Cardisure 3.5 mg/ml Oral Solution for Dogs
Cardisure 3.5 mg/ml Oral Solution for Dogs
Authorised
- Pimobendan
Product identification
Medicine name:
Cardisure 3.5 mg/ml Oral Solution for Dogs
Cardisure 3,5 mg/ml Lösung zum Eingeben für Hunde
Active substance:
- Pimobendan
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pimobendan3.50milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC01CE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Package description:
- Brown high-density polyethylene bottles fitted with white polypropylene child resistant caps, and low-density polyethylenesyringe adaptors.A low-density polyethylene oral dosing syringe with graduations is supplied with the product.Pack size:Carton box containing 1 bottle of 168 ml and a 3 ml dosing syringe
- Brown high-density polyethylene bottles fitted with white polypropylene child resistant caps, and low-density polyethylenesyringe adaptors.A low-density polyethylene oral dosing syringe with graduations is supplied with the product.Pack size:Carton box containing 1 bottle of 42 ml and a 1.5 ml dosing syringe
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- GENERA d.d.
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 839151
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0421/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 17/03/2022
Updated on: 30/08/2024
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
German (PDF)
Published on: 19/01/2022
Updated on: 30/08/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 19/01/2022
Updated on: 30/08/2024
How useful was this page?: